PolyTherics, Pro Bono Bio preclinical data

In dogs with hemophilia, subcutaneous long-acting pegylated Factor IX prolonged the amount of time free from bleeding risk by 240 hours vs. 0 hours for unmodified Factor IX. Additionally, IV long-acti...